Polyazamacrocycles as potential antitumor agents for human prostate cancer cells.

Abstract:

:Polyazamacrocycles are currently being studied and used in a variety of applications beyond their traditional place in supramolecular and co-ordination chemistry. This study suggests additional applications of these compounds with particular emphasis on their use as antiproliferative agents that could be potentially used to treat cancer. Four polyazamacrocycles were tested in human prostate cancer LNCaP and prostate epithelial PNTA1 cells to analyze changes in cell proliferation and cell death capabilities. Their intracellular localization was also evaluated by confocal microscopy. The results show a decrease in proliferation rate and cell viability of LNCaP and PNTA1, after treatment with these compounds. The decrease in the number of viable cells is similar for the majority of the compounds studied, and at higher concentration, the proliferation efficiency decreased significantly in the cell lines studied. Also, our results suggest that L and L2 induce early apoptosis in PNTA1 cells and late apoptosis/necrosis in LNCaP cells. The compounds did not induce a significant increase in necrosis of both cell types. Although the compounds did not localize in a unique organelle, all of them have as main target the Golgi apparatus and other localization profiles differed depending on the cell line.

journal_name

Chem Biol Drug Des

authors

Cruz C,Cairrão E,Lourenço O,Almeida P,Verde I,Queiroz JA

doi

10.1111/cbdd.12098

subject

Has Abstract

pub_date

2013-04-01 00:00:00

pages

517-26

issue

4

eissn

1747-0277

issn

1747-0285

journal_volume

81

pub_type

杂志文章
  • Structural characterization of inhibitors with selectivity against members of a homologous enzyme family.

    abstract::The aspartate biosynthetic pathway provides essential metabolites for many important biological functions, including the production of four essential amino acids. As this critical pathway is only present in plants and microbes, any disruptions will be fatal to these organisms. An early pathway enzyme, l-aspartate-β-se...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2011.01267.x

    authors: Pavlovsky AG,Liu X,Faehnle CR,Potente N,Viola RE

    更新日期:2012-01-01 00:00:00

  • Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2.

    abstract::Bis-indole derivatives including 1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane (DIM-C-pPhCl) and substituted quinolines such as chloroquine (CQ) and amodiaquine (AQ) are nuclear receptor 4A2 (NR4A2, Nurr1) ligands, and they exhibit anti-inflammatory activities in mouse and rat models of Parkinson's disease, respective...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章,评审

    doi:10.1111/cbdd.13564

    authors: Li X,Tjalkens RB,Shrestha R,Safe S

    更新日期:2019-10-01 00:00:00

  • Small steps to new drugs for bugs.

    abstract::Governments, academics and industry are beginning to listen to the medical communities call for new anti-bacterials. This special issue brings together diverse review articles on topics from economics and pricing to new discovery methods. ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12482

    authors: Melander RJ,Selwood DL

    更新日期:2015-01-01 00:00:00

  • An attempt to incorporate effect of direct interaction between a ligand and explicit water molecules into MM/3D-RISM.

    abstract::Endpoint methods using continuum-solvent models are widely used to estimate protein-ligand affinity. A recently developed method, MM/3D-RISM, estimates the solvation energy using statistical mechanics by 3D-RISM. This method is theoretically expected to accurately describe solvation effects and to also be less depende...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13347

    authors: Gohda K

    更新日期:2018-10-01 00:00:00

  • Effects of the TAT peptide orientation and relative location on the protein transduction efficiency.

    abstract::To understand the protein transduction domain (PTD)-mediated protein transduction behavior and to explore its potential in delivering biopharmaceutic drugs, we prepared four TAT-EGFP conjugates: TAT(+)-EGFP, TAT(-)-EGFP, EGFP-TAT(+) and EGFP-TAT(-), where TAT(+) and TAT(-) represent the original and the reversed TAT s...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2011.01315.x

    authors: Guo Q,Zhao G,Hao F,Guan Y

    更新日期:2012-05-01 00:00:00

  • Applications of machine-learning methods for the discovery of NDM-1 inhibitors.

    abstract::The emergence of New Delhi metal beta-lactamase (NDM-1)-producing bacteria and their worldwide spread pose great challenges for the treatment of drug-resistant bacterial infections. These bacteria can hydrolyze most β-lactam antibacterials. Unfortunately, there are no clinically useful NDM-1 inhibitors. In the current...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13708

    authors: Shi C,Dong F,Zhao G,Zhu N,Lao X,Zheng H

    更新日期:2020-11-01 00:00:00

  • Boosting Pose Ranking Performance via Rescoring with MM-GBSA.

    abstract::In this self-docking study, we address the so-called scoring problem. The 'scoring problem' is the inability to unambiguously identify biologically the most relevant pose, when the docking score is the main selection criterion. We use the Molecular Mechanics/Generalized Born Surface Area and ChemPLP scoring functions ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12763

    authors: Greenidge PA,Lewis RA,Ertl P

    更新日期:2016-09-01 00:00:00

  • PiViewer: An open-source tool for automated detection and display of π-π interactions.

    abstract::π-π interactions are common and important noncovalent interactions that contribute to biochemical molecular interactions, but the tools for the convenient 3D visualization of π-π interactions are lacking. We have developed an open-source and easy-to-use tool for the automated identification and display of π-π stacking...

    journal_title:Chemical biology & drug design

    pub_type: 信件

    doi:10.1111/cbdd.13340

    authors: Liu Y,Ao X,Wang Q,Wang J,Ge H

    更新日期:2018-10-01 00:00:00

  • Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro).

    abstract::Coronaviruses comprise a large group of RNA viruses with diverse host specificity. The emergence of highly pathogenic strains like the SARS coronavirus (SARS-CoV), and the discovery of two new coronaviruses, NL-63 and HKU1, corroborates the high rate of mutation and recombination that have enabled them to cross specie...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2008.00679.x

    authors: Bacha U,Barrila J,Gabelli SB,Kiso Y,Mario Amzel L,Freire E

    更新日期:2008-07-01 00:00:00

  • Geniposide Attenuates the Phosphorylation of Tau Protein in Cellular and Insulin-deficient APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.

    abstract::Our previous studies have shown that geniposide plays an essential role in glucose-stimulated insulin secretion from pancreatic β cells and also regulates the metabolism of Aβ and its deposition in neurons. In this study, we reported that insulin deficiency induced significant increase of tau phosphorylation. Administ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12673

    authors: Zhang Y,Yin F,Liu J,Liu Z

    更新日期:2016-03-01 00:00:00

  • A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.

    abstract::We previously designed and reported a novel class of drugs, namely hybrid peptides, which are chemically synthesized and composed of a targeted binding peptide and a lytic-type peptide containing cationic amino acid residues that cause cancer cell death. In the present study, we screened for peptides that bind to inte...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13517

    authors: Kurihara R,Horibe T,Shimizu E,Torisawa A,Gaowa A,Kohno M,Kawakami K

    更新日期:2019-07-01 00:00:00

  • Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.

    abstract::To address the problem of specificity in G-protein coupled receptor (GPCR) drug discovery, there has been tremendous recent interest in allosteric drugs that bind at sites topographically distinct from the orthosteric site. Unfortunately, structure-based drug design of allosteric GPCR ligands has been frustrated by th...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2010.01012.x

    authors: Ivetac A,McCammon JA

    更新日期:2010-09-01 00:00:00

  • Molecular dynamics insights on the role β-augmentation of the peptide N-terminus with binding site β-hairpin of proprotein convertase subtilisin/kexin 9.

    abstract::PCSK9, a member of the proprotein convertase family, is a key negative regulator of hepatic low-density lipoprotein receptor (LDLR) concentrations in the blood plasma and is associated with the risk of coronary artery disease (CAD). Peptide inhibitors designed to block PCSK9-LDLR interactions could reduce the risk of ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13612

    authors: Pasam B,Medicherla KM,Rathore RS,Upadhyayula RS

    更新日期:2019-12-01 00:00:00

  • Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design.

    abstract::Protein flexibility plays a major role in biomolecular recognition. In many cases, it is not obvious how molecular structure will change upon association with other molecules. In proteins, these changes can be major, with large deviations in overall backbone structure, or they can be more subtle as in a side-chain rot...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章,评审

    doi:10.1111/cbdd.12051

    authors: Sinko W,Lindert S,McCammon JA

    更新日期:2013-01-01 00:00:00

  • Effects of drug hydrophobicity on liposomal stability.

    abstract::A major obstacle in drug delivery is the inability to effectively deliver drugs to their intended biological target without deleterious side-effects. Delivery vehicles such as liposomes can minimize toxic side-effects by shielding the drug from reaction with unintended targets while in systemic circulation. Liposomes ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2007.00610.x

    authors: Khan DR,Rezler EM,Lauer-Fields J,Fields GB

    更新日期:2008-01-01 00:00:00

  • The TATA-binding Protein DNA-binding domain of eukaryotic parasites is a potentially druggable target.

    abstract::The TATA-binding protein (TBP) is a central transcription factor in eukaryotes that interacts with a large number of different transcription factors; thus, affecting these interactions will be lethal for any living being. In this work, we present the first structural and dynamic computational study of the surface prop...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13630

    authors: Santiago Á,Razo-Hernández RS,Pastor N

    更新日期:2020-01-01 00:00:00

  • Synthesis, Activity, and Docking Study of Novel Phenylthiazole-Carboxamido Acid Derivatives as FFA2 Agonists.

    abstract::Free fatty acid receptor 2 (FFA2), also known as GPR43, is activated by short-chain fatty acids (SCFAs) that are mainly produced by the gut microbiota through the fermentation of undigested carbohydrates and dietary fibers. FFA2 currently appears to be a potential target in the management of obesity, diabetes, inflamm...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12729

    authors: Ma L,Wang T,Shi M,Fu P,Pei H,Ye H

    更新日期:2016-07-01 00:00:00

  • Combined in silico and experimental approach for drug design: the binding mode of peptidic and non-peptidic inhibitors to hsp90 N-terminal domain.

    abstract::Heat shock protein 90 (Hsp90) is a prime target for antitumor therapies. The information obtained by molecular dynamics (MD) simulations is combined with NMR data to provide a cross-validated atomic resolution model of the complementary interactions of heat shock protein 90 with a peptidic (shepherdin) and a non-pepti...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2010.01015.x

    authors: Tomaselli S,Meli M,Plescia J,Zetta L,Altieri DC,Colombo G,Ragona L

    更新日期:2010-11-01 00:00:00

  • Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.

    abstract::Chemotherapy is currently the only effective approach to treat all forms of leishmaniasis. However, its effectiveness is severely limited due to high toxicity, long treatment length, drug resistance, or inadequate mode of administration. As a consequence, there is a need to identify new molecular scaffolds and targets...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13326

    authors: De Luca L,Ferro S,Buemi MR,Monforte AM,Gitto R,Schirmeister T,Maes L,Rescifina A,Micale N

    更新日期:2018-09-01 00:00:00

  • Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.

    abstract::Phenol and its congeners are known to induce caspase-mediated apoptosis activity and cytotoxicity on various cancer cell lines. Apoptosis, scavenging of radicals, antioxidant, and pro-oxidant characteristics are primarily responsible for the antitumor activities of phenolic compounds. Quantitative structure-activity r...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2007.00575.x

    authors: Nandi S,Vracko M,Bagchi MC

    更新日期:2007-11-01 00:00:00

  • Probing the Binding Pocket of the Broadly Tuned Human Bitter Taste Receptor TAS2R14 by Chemical Modification of Cognate Agonists.

    abstract::Sensing potentially harmful bitter substances in the oral cavity is achieved by a group of (˜) 25 receptors, named TAS2Rs, which are expressed in specialized sensory cells and recognize individual but overlapping sets of bitter compounds. The receptors differ in their tuning breadths ranging from narrowly to broadly t...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12734

    authors: Karaman R,Nowak S,Di Pizio A,Kitaneh H,Abu-Jaish A,Meyerhof W,Niv MY,Behrens M

    更新日期:2016-07-01 00:00:00

  • Homology modeling, docking studies and molecular dynamic simulations using graphical processing unit architecture to probe the type-11 phosphodiesterase catalytic site: a computational approach for the rational design of selective inhibitors.

    abstract::Phosphodiesterase 11 (PDE11) is the latest isoform of the PDEs family to be identified, acting on both cyclic adenosine monophosphate and cyclic guanosine monophosphate. The initial reports of PDE11 found evidence for PDE11 expression in skeletal muscle, prostate, testis, and salivary glands; however, the tissue distr...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12193

    authors: Cichero E,D'Ursi P,Moscatelli M,Bruno O,Orro A,Rotolo C,Milanesi L,Fossa P

    更新日期:2013-12-01 00:00:00

  • Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.

    abstract::Aberrant activation of the phosphoinositide 3-kinase pathway because of genetic mutations of essential signalling proteins has been associated with human diseases including cancer and diabetes. The pivotal role of 3-phosphoinositide-dependent kinase-1 in the PI3K signalling cascade has made it an attractive target for...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2008.00768.x

    authors: Stockman BJ,Kothe M,Kohls D,Weibley L,Connolly BJ,Sheils AL,Cao Q,Cheng AC,Yang L,Kamath AV,Ding YH,Charlton ME

    更新日期:2009-02-01 00:00:00

  • Discovery of novel acyl coenzyme a: cholesterol acyltransferase inhibitors: pharmacophore-based virtual screening, synthesis and pharmacology.

    abstract::The present study describes ligand-based pharmacophore modeling of a series of structurally diverse acyl coenzyme A cholesterol acyltransferase inhibitors. Quantitative pharmacophore models were generated using HypoGen module of Discovery Studio 2.1, whereby the best pharmacophore model possessing two hydrophobic, one...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2012.01384.x

    authors: Chhabria MT,Brahmkshatriya PS,Mahajan BM,Darji UB,Shah GB

    更新日期:2012-07-01 00:00:00

  • Target-specific anti-fungal discovery by targeting Geotrichum candidum histidinol dehydrogenase: a hybrid approach.

    abstract::This study describes a hybrid approach of screening substrate analogue inhibitors of histidinol dehydrogenase. Imidazole derivative library of approximately 400 compounds classified using Hierarchical cluster analysis, representative compounds of each class were tested in enzymatic assay and used for the development o...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2008.00692.x

    authors: Pahwa S,Chavan AG,Jain R,Roy N

    更新日期:2008-09-01 00:00:00

  • Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.

    abstract::New series of chrysin derivatives (4a-4t) were designed and synthesized by introducing different substituted piperazines at C-7 position. Their inhibitory effects on FabH were evaluated using two Gram-negative bacterial strains, Escherichia coli and Pseudomonas aeruginosa, and two Gram-positive bacterial strains, Baci...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12839

    authors: Li HX,Wang ZC,Qian YM,Yan XQ,Lu YD,Zhu HL

    更新日期:2017-01-01 00:00:00

  • Pharmacological evaluation of imidazole-derived bisphosphonates on receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation and function.

    abstract::Bisphosphonates (BPs) have been commonly used in the treatment of osteolytic bone lesions, such as osteoporosis and osteogenesis imperfecta. However, serious side-effects can occur during the therapy. To search for novel potent BPs with lower side-effects, a series of imidazole-containing BPs (zoledronic acid [ZOL]; Z...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13767

    authors: Lin J,Peng Y,Liu Q,Li K,Lv G,Seimbille Y,Huang G,Gao F,Qiu L

    更新日期:2021-01-01 00:00:00

  • Rhodanine derivatives as selective protease inhibitors against bacterial toxins.

    abstract::In this study, we analyzed a series of rhodanine derivatives, as potential inhibitors of bacterial toxins, namely the proteases anthrax lethal factor and the botulinum neurotoxin type A. Conducting an extensive structure-activity relationship study on rhodanine derivatives, we profiled their selectivity against the tw...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2007.00617.x

    authors: Johnson SL,Chen LH,Harbach R,Sabet M,Savinov A,Cotton NJ,Strongin A,Guiney D,Pellecchia M

    更新日期:2008-02-01 00:00:00

  • Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.

    abstract::Tubulin inhibition represents an established target in the field of anticancer research, and over the last 20 years, an intensive search for new antimicrotubule agents has occurred. Indeed, in silico models have been presented that might aid the discovery of novel agents. Among these, a 7-point pharmacophore model has...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2011.01245.x

    authors: Massarotti A,Theeramunkong S,Mesenzani O,Caldarelli A,Genazzani AA,Tron GC

    更新日期:2011-12-01 00:00:00

  • Tumor targeting with 99m Tc radiolabeled peptides: Clinical application and recent development.

    abstract::Targeting overexpressed receptors on the cancer cells with radiolabeled peptides has become very important in nuclear oncology in the recent years. Peptides are small and have easy preparation and easy radiolabeling protocol with no side-effect and toxicity. These properties made them a valuable tool for tumor targeti...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章,评审

    doi:10.1111/cbdd.13413

    authors: Rezazadeh F,Sadeghzadeh N

    更新日期:2019-03-01 00:00:00